Biotech & Pharma.T.A, Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A,

BIB 75.48

+1.4%

Nov 14 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Jibacoa who wrote (2899)	6/9/2010 2:38:46 PM
From: Jibacoa	1 Recommendation Read Replies (2) of 3722

PBTH is up 9.02% with volume > 509Ks which is > 2.7x its ADV bigcharts.marketwatch.com As previously mentioned, PBTH develops long-acting versions of already approved therapeutic proteins. Its CTP technology (carboxyl-terminal peptide) appears to be applicable to virtually all proteins. Initially, PBTH is developing long-acting versions of human growth hormone, interferon beta, factor VII, factor IX and EPO (erythropoietin). The current versions of these products are already in the market, and generate billions of dollars annually. But by extending the half life or efficacy window,the CTP reduces the cost and improves compliance for millions of patients reliant upon biotech proteins. PBTH believes these CTP-enhanced products,have the potential to address biopharmaceutical markets estimated at more than $25 billion. <g> PBTH is making another all time H <g> The ACTAY is $8 But I will continue to pick up some shares whenever the opportunity presents.<g> bigcharts.marketwatch.com Bernard

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next